MicroRNA-124 targets CCNA2 and regulates cell cycle in STHdhQ111/HdhQ111 cells

Biochemical and Biophysical Research Communications

Volumn 437, Issue 2, 2013, Pages 217-224

  Das, Eashita ^a   Jana, Nihar Ranjan ^b   Bhattacharyya, Nitai Pada ^a  

^a SAHA INSTITUTE OF NUCLEAR PHYSICS   (India)

^b NATIONAL BRAIN RESEARCH CENTRE   (India)

Author keywords

Cell cycle; Cyclin A2; Huntington's disease; MicroRNA 124; STHdhQ111 HdhQ111 cells; STHdhQ7 HdhQ7 cells

Indexed keywords

ANIMAL CELL; ARTICLE; CELL CYCLE; CELL CYCLE S PHASE; CONTROLLED STUDY; CORPUS STRIATUM; CYCLIN A2 GENE; DOWN REGULATION; GENE; GENE EXPRESSION; GENE TARGETING; MICRORNA 124 GENE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

3′-UNTRANSLATED REGION; 3′-UTR; CCNA2; CELL CYCLE; CYCLIN A2; HD; HUNTINGTON'S DISEASE; MICRO RNA; MICRORNA-124; MIRNA; STHDH(Q111)/HDH(Q111) CELLS; STHDH(Q7)/HDH(Q7) CELLS;

ANIMALS; BASE SEQUENCE; CELL CYCLE; CORPUS STRIATUM; CYCLIN A2; DNA PRIMERS; MICE; MICRORNAS; RNA, SMALL INTERFERING;

ANIMALIA; MUS;

EID: 84880755045     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2013.06.041     Document Type: Article

References (36)

1. Cheng A.M., Byrom M.W., Shelton J., et al. Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis. Nucleic Acids Res. 2005, 33:1290-1297.
2. Tay Y., Zhang J., Thomson A.M., et al. MicroRNAs to Nanog, Oct4 and Sox2 coding regions modulate embryonic stem cell differentiation. Nature 2008, 455:1124-1128.
3. Blakaj A., Lin H. Piecing together the mosaic of early mammalian development through microRNAs. J. Biol. Chem. 2008, 283:9505-9508.
4. Stefani G., Slack F.J. Small non-coding RNAs in animal development. Nat. Rev. Mol. Cell Biol. 2008, 9:219-230.
5. Cloonan N., Brown M.K., Steptoe A.L., et al. The miR-17-5p microRNA is a key regulator of the G1/S phase cell cycle transition. Genome Biol. 2008, 9:R127.
6. Xia H., Qi Y., Ng S.S., et al. MicroRNA-15b regulates cell cycle progression by targeting cyclins in glioma cells. Biochem. Biophys. Res. Commun. 2009, 380:205-210.
7. Xia L., Zhang D., Du R., et al. MiR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells. Int. J. Cancer 2008, 123:372-379.
8. Ruepp A., Kowarsch A., Schmidl D., et al. PhenomiR: a knowledgebase for microRNA expression in diseases and biological processes. Genome Biol. 2010, 11:R6.
9. Sinha M., Ghose J., Das E., et al. Altered microRNAs in STHdh(Q111)/Hdh(Q111) cells: miR-146a targets TBP. Biochem. Biophys. Res. Commun. 2010, 396:742-747.
10. Johnson R., Zuccato C., Belyaev N.D., et al. A microRNA-based gene dysregulation pathway in Huntington's disease. Neurobiol. Dis. 2008, 29:438-445.
11. Marti E., Pantano L., Banez-Coronel M., et al. A myriad of miRNA variants in control and Huntington's disease brain regions detected by massively parallel sequencing. Nucleic Acids Res. 2010, 38:7219-7235.
12. Packer A.N., Xing Y., Harper S.Q., et al. The bifunctional microRNA miR-9/miR-9* regulates REST and CoREST and is downregulated in Huntington's disease. J. Neurosci. 2008, 28:14341-14346.
13. Sinha M., Ghose J., Bhattarcharyya N.P. Micro RNA -214,-150,-146a and-125b target Huntingtin gene. RNA Biol. 2011, 8:1005-1021.
14. Ghose J., Sinha M., Das E., et al. Regulation of miR-146a by RelA/NFkB and p53 in STHdh(Q111)/Hdh(Q111) cells, a cell model of Huntington's disease. PLoS ONE 2011, 6:e23837.
15. Sinha M., Mukhopadhyay S., Bhattacharyya N.P. Mechanism(s) of alteration of micro RNA expressions in Huntington's disease and their possible contributions to the observed cellular and molecular dysfunctions in the disease. Neuromolecular Med. 2012, 14:221-243.
16. Wang W., Bu B., Xie M., et al. Neural cell cycle dysregulation and central nervous system diseases. Prog. Neurobiol. 2009, 89:1-17.
17. Herrup K., Yang Y. Cell cycle regulation in the postmitotic neuron: oxymoron or new biology?. Nat. Rev. Neurosci. 2007, 8:368-378.
18. Folch J., Junyent F., Verdaguer E., et al. Role of cell cycle re-entry in neurons: a common apoptotic mechanism of neuronal cell death. Neurotox. Res. 2012, 22:195-207.
19. Pelegri C., Duran-Vilaregut J., del Valle J., et al. Cell cycle activation in striatal neurons from Huntington's disease patients and rats treated with 3-nitropropionic acid. Int. J. Dev. Neurosci. 2008, 26:665-671.
20. Trettel F., Rigamonti D., Hilditch-Maguire P., et al. Dominant phenotypes produced by the HD mutation in STHdh(Q111) striatal cells. Hum. Mol. Genet. 2000, 9:2799-2809.
21. Raychaudhuri S., Sinha M., Mukhopadhyay D., et al. HYPK, a Huntingtin interacting protein, reduces aggregates and apoptosis induced by N-terminal Huntingtin with 40 glutamines in Neuro2a cells and exhibits chaperone-like activity. Hum. Mol. Genet. 2008, 17:240-255.
22. Datta M., Choudhury A., Lahiri A., et al. Genome wide gene expression regulation by HIP1 Protein Interactor, HIPPI: prediction and validation. BMC Genomics 2011, 12:463.
23. Choudhury K.R., Raychaudhuri S., Bhattacharyya N.P. Identification of HYPK-interacting proteins reveals involvement of HYPK in regulating cell growth, cell cycle, unfolded protein response and cell death. PLoS ONE 2012, 7:e51415.
24. Maheshwari M., Samanta A., Godavarthi S.K., et al. Dysfunction of the ubiquitin ligase Ube3a may be associated with synaptic pathophysiology in a mouse model of Huntington disease. J. Biol. Chem. 2012, 287:29949-29957.
25. Nogales-Cadenas R., Carmona-Saez P., Vazquez M., et al. GeneCodis: interpreting gene lists through enrichment analysis and integration of diverse biological information. Nucleic Acids Res. 2009, 37:W317-W322.
26. Gines S., Seong I.S., Fossale E., et al. Specific progressive cAMP reduction implicates energy deficit in presymptomatic Huntington's disease knock-in mice. Hum. Mol. Genet. 2003, 12:497-508.
27. Zuccato C., Belyaev N., Conforti P., et al. Widespread disruption of repressor element-1 silencing transcription factor/neuron-restrictive silencer factor occupancy at its target genes in Huntington's disease. J. Neurosci. 2007, 27:6972-6983.
28. Benn C.L., Sun T., Sadri-Vakili G., et al. Huntingtin modulates transcription, occupies gene promoters in vivo, and binds directly to DNA in a polyglutamine-dependent manner. J. Neurosci. 2008, 28:10720-10733.
29. Turmaine M., Raza A., Mahal A., et al. Nonapoptotic neurodegeneration in a transgenic mouse model of Huntington's disease. Proc. Natl. Acad. Sci. USA 2000, 97:8093-8097.
30. Datta M., Bhattacharyya N.P. Regulation of RE1 protein silencing transcription factor (REST) expression by HIP1 protein interactor (HIPPI). J. Biol. Chem. 2011, 286:33759-33769.
31. Ebert M.S., Sharp P.A. Roles for microRNAs in conferring robustness to biological processes. Cell 2012, 149:515-524.
32. Huang L., Luo J., Cai Q., et al. MicroRNA-125b suppresses the development of bladder cancer by targeting E2F3. Int. J. Cancer 2011, 128:1758-1769.
33. Pagano M., Pepperkok R., Verde F., et al. Cyclin A is required at two points in the human cell cycle. EMBO J. 1992, 11:961-971.
34. Tane S., Chibazakura T. Cyclin A overexpression induces chromosomal double-strand breaks in mammalian cells. Cell Cycle 2009, 8:3900-3903.
35. Chibazakura T., McGrew S.G., Cooper J.A., et al. Regulation of cyclin-dependent kinase activity during mitotic exit and maintenance of genome stability by p21, p27, and p107. Proc. Natl. Acad. Sci. USA 2004, 101:4465-4470.
36. Fernandez-Fernandez M.R., Ferrer I., Lucas J.J. Impaired ATF6alpha processing, decreased Rheb and neuronal cell cycle re-entry in Huntington's disease. Neurobiol. Dis. 2011, 41:23-32.